Phospholipid nanodisc engineering for drug delivery systems

Biotechnology Journal

Volumn 7, Issue 6, 2012, Pages 762-767

  Murakami, Tatsuya ^a  

^a KYOTO UNIVERSITY   (Japan)

Author keywords

Biochemical engineering; Drug delivery; Nanobiotechnology

Indexed keywords

ANTIGENICITY; BI-LAYER; BICELLES; CELL TARGETING; CELLULAR UPTAKE; CLINICAL TRIAL; DRUG CARRIER; DRUG DELIVERY SYSTEM; DRUG LOADING; GENE DELIVERY; HIGH-DENSITY LIPOPROTEINS; IN-VITRO; MESOSCALE; NANODISCS; NATURALLY OCCURRING; POLYMER MICELLES; POTENTIAL PROBLEMS; RETICULOENDOTHELIAL SYSTEMS; SIZE-CONTROL;

BIOCHEMICAL ENGINEERING; BIOCOMPATIBILITY; BIOSYNTHESIS; COATINGS; DRUG DELIVERY; GENE TRANSFER; LIPOSOMES; LOADING; NANOBIOTECHNOLOGY; NANOPARTICLES; POLYETHYLENE GLYCOLS; RECOMBINANT PROTEINS;

PHOSPHOLIPIDS;

APOLIPOPROTEIN A; HIGH DENSITY LIPOPROTEIN; MACROGOL; NANODISC; PHOSPHOLIPID;

ANTIGENICITY; BIOMEDICAL ENGINEERING; DRUG DELIVERY SYSTEM; GENE DELIVERY SYSTEM; GENETIC ENGINEERING; MATERIAL COATING; PARTICLE SIZE; PHOSPHOLIPID BILAYER; PHOSPHOLIPID NANODISC ENGINEERING; PRIORITY JOURNAL; SHORT SURVEY;

ANIMALS; BIOCOMPATIBLE MATERIALS; DRUG DELIVERY SYSTEMS; HUMANS; LIPOPROTEINS, HDL; NANOPARTICLES; PHOSPHOLIPIDS; POLYETHYLENE GLYCOLS; PROTEIN ENGINEERING;

EID: 84861768149     PISSN: 18606768     EISSN: 18607314     Source Type: Journal    
DOI: 10.1002/biot.201100508     Document Type: Short Survey

References (56)

1. Linsel-Nitschke, P., Tall, A. R., HDL as a target in the treatment of atherosclerotic cardiovascular disease. Nat. Rev. Drug Discov. 2005, 4, 193-206.
2. Jonas, A., Hefele Wald, J., Harms Toohill, K. L., Krul, E. S., Kézdy, K. E., Apolipoprotein A-I structure and lipid properties in homogenous, reconstituted spherical and discoidal high density lipoproteins. J. Biol. Chem. 1990, 265, 22123-22129.
3. Matz, C. E., Jonas, A., Micellar complexes of human apolipoprotein A-I with phosphatidylcholines and cholesterol prepared from cholate-lipid dispersions. J. Biol. Chem. 1982, 257, 4535-4540.
4. Bricarello, D. A., Smilowitz, J. T., Zivkovic, A. M., German, B., Parikh, A. N., Reconstituted lipoprotein: a versatile class of biologically-inspired nanostructures. ACS Nano 2011, 5, 42-57.
5. Lacko, A. G., Nair, M., Prokai, L., McConathy, W. J., Prospects and challenges of the development of lipoprotein-based formulations for anti-cancer drugs. Expert Opin. Drug Deliv. 2007, 4, 665-675.
6. Marchesi, M., Sirtori, C. R., Therapeutic use of the high-density lipoprotein protein and peptides. Expert Opin. Investig. Drugs 2006, 15, 227-241.
7. Ng, K. K., Lovell, J. F., Zheng, G., Lipoprotein-inspired nanoparticles for cancer theranostics. Acc. Chem. Res. 2011, 44, 1105-1113.
8. Rensen, P. C. N., de Vrueh, R. L. A., Kuiper, J., Bijsterbosch, M. K. et al., Recombinant lipoproteins: lipoprotein-like lipid particles for drug targeting. Adv. Drug Deliv. Rev. 2001, 47, 251-276.
9. Ryan, R. O., Nanodisks: hydrophobic drug delivery vehicles. Expert Opin. Drug Deliv. 2008, 5, 343-351.
10. Ryan, R. O., Nanobiotechnology applications of reconstituted high density lipoprotein. J. Nanobiotechnol. 2010, 8, 28-37.
11. Bayburt, T. H., Sligar, S. G., Membrane protein assembly into nanodiscs. FEBS Lett. 2010, 584, 1721-1727.
12. Borch, J., Hamann, T., The nanodisc: a novel tool for membrane protein studies. Biol. Chem. 2009, 390, 805-814.
13. Ritchie, T. K., Grinkova, Y. V., Bayburt, T. H., Denisov, I. G., et al., Chapter 11 - Reconstitution of membrane proteins in phospholipid bilayer nanodiscs, in: Duzgunes, N. (Ed.), Methods Enzymol., Academic Press, Inc., Orland 2009, pp. 211-231.
14. Nath, A., Grinkova, Y. V., Sligar, S. G., Atkins, W. N., Ligand binding to cytochrome P450 3A4 in phospholipid bilayer nanodiscs: The effect of model membranes. J. Biol. Chem. 2007, 282, 28309-28320.
15. Johnston, L. J., Nanoscale imaging of domains in supported lipid membranes. Langmuir 2007, 23, 5886-5895.
16. Bayburt, T. H., Carlson, J. W., Sligar, S. G., Reconstitution and imaging of a membrane protein in a nanometer-size phospholipid bilayer. J. Struct. Biol. 1998, 123, 37-44.
17. Bayburt, T. H., Grinkova, Y. V., Sligar, S. G., Self-assembly of discoidal phospholipid bilayer nanoparticles with membrane scaffoled proteins. Nano Lett. 2002, 2, 853-856.
18. Skar-Gislinge, N., Simonsen, J. B., Mortensen, K., Feidenhans'l, R. et al., Elliptical structure of phospholipid bilayer nanodiscs encapsulated by scaffold proteins: casting the roles of the lipids and the protein. J. Am. Chem. Soc. 2010, 132, 13713-13722.
19. Wu, Z., Gogonea, V., Lee, X., Wagner, M. A. et al., Double superhelix model of high density lipoprotein. J. Biol. Chem. 2009, 284, 36605-36619.
20. Oda, M. N., Hargreaves, P. L., Beckstead, J. A., Redmond, K. A. et al., Reconstituted high density lipoprotein enriched with the polyene antibiotic amphotericin B. J. Lipid Res. 2006, 47, 260-267.
21. Nguyen, T.-S., Weers, P. M. M., Raussens, V., Wang, Z. et al., Amphotericin B induces interdigitation of apolipoprotein stabilized nanodisk bilayers. Biochim. Biophys. Acta 2008, 1778, 303-312.
22. Nelson, K. G., Bishop, J., Ryan, R. O., Titus, R., Nanodisk-associated amphotericin B clears Leishmania major cutaneous infection in susceptible BALB/c mice. Antimicrob. Agents Chemother. 2006, 50, 1238-1244.
23. Burgess, B. L., Cavigiolio, G., Fannucchi, M. V., Illek, B. et al., A phospholipid-apolipoprotein A-I nanoparticle containing amphotericin B as a drug delivery platform with cell membrane protective properties. Int. J. Pharm. 2010, 399, 148-155.
24. Tufteland, M., Ren, G., Ryan, R. O., Nanodisks derived from amphotericin B lipid complex. J. Pharm. Sci. 2008, 97, 4425-4432.
25. Redmond, K. A., Nguyen, T.-S., Ryan, R. O., All-trans-retinoic acid nanodisks. Int. J. Pharm. 2007, 339, 246-250.
26. Singh, A. T. K., Evens, A. M., Anderson, R. J., Beckstead, J. A. et al., All trans retinoic acid nanodisks enhance retinoic acid receptor mediated apoptosis and cell cycle arrest in mantle cell lymphoma. Br. J. Haematol. 2010, 150, 158-169.
27. Ghosh, M., Singh, A. T. K., Xu, W., Sulchek, T. et al., Curcumin nanodisks: formulation and characterization. Nanomed. 2011, 7, 162-167.
28. Lou, B., Liao, X.-L., Wu, M.-P., Cheng, P.-F. et al., High-density lipoprotein as a potential carrier for delivery of a lipophilic antitumoral drug into hepatoma cells. World J. Gastroenterol. 2005, 11, 954-959.
29. Feng, M., Cai, Q., Shi, X., Huang, X. et al., Recombinant high-density lipoprotein complex as a targeting system of nosiheptide to liver cells. J. Drug Targeting 2008, 16, 502-508.
30. Wolfrum, C., Shi, S., Jayaprakash, K. N., Jayaraman, M. et al., Mechanisms and optimization of in vivo delivery of lipophilic siRNA. Nat. Biotechnol. 2007, 25, 1149-1157.
31. Mishra, S., Webster, P., Davis, M. E., PEGylation significantly affects cellular uptake and intracellular trafficking of non-viral gene delivery particles. Eur. J. Cell Biol. 2004, 83, 97-111.
32. Remaut, K., Lucas, B., Braeckmans, K., Demeester, J., De Smedt, S. C., Pegylation of liposomes favours the endosomal degradation of the delivered phosphodiester oligonucleotides. J. Control. Release 2007, 117, 256-266.
33. Song, L. Y., Ahkong, Q. F., Rong, Q., Wang, Z. et al., Characterization of the inhibitory effect of PEG-lipid conjugates on the intracellular delivery of plasmid and antisense DNA mediated by cationic lipid liposomes. Biochim. Biophys. Acta 2002, 1558, 1-13.
34. Cheng, T.-L., Wu, P.-Y., Wu, M.-F., Chern, J.-W., Roffler, S. R., Accelerated clearance of polyethylene glycol-modified proteins by anti-polyethylene glycol IgM. Bioconjug. Chem. 1999, 10, 520-528.
35. Ishida, T., Atobe, K., Wang, X. Y., Kiwada, H., Accelerated blood clearance of PEGylated liposomes upon repeated injections: effect of doxorubicin-encapsulation and high-dose first injection. J. Control. Release 2006, 115, 251-258.
36. Wang, X., Ishida, T., Kiwada, H., Anti-PEG IgM elicited by injection of liposomes is involved in the enhanced blood clearance of a subsequent dose of PEGylated liposomes. J. Control. Release 2007, 119, 236-244.
37. Hatakeyama, H., Akita, H., Harashima, H., A multifunctional envelope type nano device (MEND) for gene delivery to tumours based on the EPR effect: a strategy for overcoming the PEG dilemma. Adv. Drug Deliv. Rev. 2011, 63, 152-160.
38. Grosse, S. M., Tagalakis, A. D., Mustapa, M. F. M., Elbs, M. et al., Tumor-specific gene transfer with receptor-mediated nanocomplexes modified by polyethylene glycol shielding and endosomally cleavable lipid and peptide linkers. FASEB J. 2010, 24, 2301-2313.
39. Murakami, T., Wijagkanalan, W., Hashida, M., Tsuchida, K., Intracellular drug delivery by genetically engineered high density lipoprotein nanoparticles. Nanomed. (Lond) 2010, 5, 867-879.
40. Corbin, I. R., Chen, J., Cao, W., Li, H. et al., Enhanced cancer-targeted delivery using engineered high-density lipoprotein-based nanocarriers. J. Biomed. Nanotechnol. 2007, 3, 367-376.
41. Chen, W., Jarzyna, P. A., van Tilborg, G. A. F., Nguyen, V. A. et al., RGD peptide functionalized and reconstituted high-density lipoprotein nanoparticles as a versatile and multimodal tumor targeting molecular imaging probe. FASEB J. 2010, 24, 1689-1699.
42. Lee, H., Hu, M., Reilly, R. M., Allen, C., Apoptotic epidermal growth factor (EGF)-conjugated block copolymer micelles as a nanotechnology platform for targeted combination therapy. Mol. Pharm. 2007, 4, 769-781.
43. Nishikawa, K., Asai, T., Shigematsu, H., Shimizu, K. et al., Development of anti-HB-EGF immunoliposomes for the treatment of breast cancer. J. Control. Release 2011, doi: 10.1016/j.jconrel.2011.10.010.
44. Sigot, V., Arndt-Jovin, D. J., Jovin, T. M., Targeted cellular delivery of quantum dots loaded on and in biotinylated liposomes. Bioconjug. Chem. 2010, 21, 1465-1472.
45. Tseng, C.-L., Su, W. Y., Yen, K. C., Yang, K. C., Lin, F. H., The use of biotinylated-EGF-modified gelatin nanoparticle carrier to enhance cisplatin accumulation in cancerous lungs via inhalation. Biomaterials 2009, 30, 3476-3485.
46. Iovannisci, D. M., Beckstead, J. A., Ryan, R. O., Targeting nanodisks via a single chain variable antibody-apolipoprotein chimera. Biochem. Biophys. Res. Commun. 2009, 379, 466-469.
47. Uno, Y., Piao, W., Miyata, K., Nishina, K. et al., High-density lipoprotein facilitates in vivo delivery of α-tocopherol-conjugated short-interfering RNA to the brain. Hum. Gene Ther. 2011, 22, 711-719.
48. Lee, H., Kim, S. I., Shin, D., Yoon, Y. et al., Hepatic siRNA delivery using recombinant human apolipoprotein A-I in mice. Biochem. Biophys. Res. Commun. 2009, 378, 192-196.
49. Das, A., Sligar, S. G., Modulation of the cytchrome P450 reductase redox potential by the phospholipid bilayer. Biochemistry 2009, 48, 12104-12112.
50. Zhang, Z., Chen, J., Ding, L., Jin, H. et al., HDL-mimicking peptide-lipid nanoparticles with improved tumor targeting. Small 2010, 6, 430-437.
51. Buehler, D. C., Toso, D. B., Kickhoefer, V. A., Zhou, H., Rome, L. H., Vaults engineered for hydrophobic drug delivery. Small 2011, 7, 1432-1439.
52. Cabral, H., Matsumoto, Y., Mizuno, K., Chen, Q. et al., Accumulation of sub-100 nm polymeric micelles in poorly permeable tumours depends on size. Nat. Nanotechnol. 2011, 6, 815-823.
53. Matsumura, Y., Maeda, H., A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent Smancs. Cancer Res. 1986, 46, 6387-6392.
54. Harrington, K. J., Mohammadtaghi, S., Uster, P. S., Glass, D. et al., Effective targeting of solid tumors in patients with locally advanced cancers by radiolabeled pegylated liposomes. Clin. Cancer Res. 2001, 7, 243-254.
55. Nakanishi, T., Fukushima, S., Okamoto, K., Suzuki, M. et al., Development of the polymer micelle carrier system for doxorubicin. J. Control. Release 2001, 74, 295-302.
56. Murakami, T., Tsuchida, K., Hashida, M., Imahori, H., Size control of lipid-based drug carriers by drug loading. Mol. BioSyst. 2010, 6, 789-791.